137 related articles for article (PubMed ID: 36653491)
41. Intellectual property. China's innovation landscape.
Huang KG
Science; 2010 Aug; 329(5992):632-3. PubMed ID: 20689003
[No Abstract] [Full Text] [Related]
42. Intellectual property and biomedical innovation in the context of Canadian federalism.
de Beer J; Brusnyk C
Health Law J; 2011; 19():45-82. PubMed ID: 23185902
[No Abstract] [Full Text] [Related]
43. [The Status of Industry and Supervision of Medical Devices for Human Assisted Reproductive Technology in China].
Sun X; Han Q
Zhongguo Yi Liao Qi Xie Za Zhi; 2021 Nov; 45(6):591-593. PubMed ID: 34862767
[TBL] [Abstract][Full Text] [Related]
44. The impact of intellectual property rights on health care in Canada.
Penner MD; Abouali A
Health Law Can; 2008 Jun; 28(3-4):89-101. PubMed ID: 19051969
[TBL] [Abstract][Full Text] [Related]
45. Intellectual property. University licensing and the Bayh-Dole Act.
Thursby JG; Thursby MC
Science; 2003 Aug; 301(5636):1052. PubMed ID: 12933996
[No Abstract] [Full Text] [Related]
46. Intellectual Property and biodiversity: interplay.
Bhola R; Dave S
Pharm Pat Anal; 2017 May; 6(3):105-114. PubMed ID: 28485650
[TBL] [Abstract][Full Text] [Related]
47. Intellectual property. Enhanced: intellectual property landscape of the human genome.
Jensen K; Murray F
Science; 2005 Oct; 310(5746):239-40. PubMed ID: 16224006
[TBL] [Abstract][Full Text] [Related]
48. China steps up US biotech intellectual property land grab.
Ratner M
Nat Biotechnol; 2008 Feb; 26(2):141-2. PubMed ID: 18259157
[No Abstract] [Full Text] [Related]
49. Data sharing and intellectual property in a genomic epidemiology network: policies for large-scale research collaboration.
Chokshi DA; Parker M; Kwiatkowski DP
Bull World Health Organ; 2006 May; 84(5):382-7. PubMed ID: 16710548
[TBL] [Abstract][Full Text] [Related]
50. Commercial applicability of cell microancapsulation: a review of intellectual property rights.
Meier SM
Adv Exp Med Biol; 2010; 670():137-44. PubMed ID: 20384224
[TBL] [Abstract][Full Text] [Related]
51. The intellectual property cookbook: a guide for the novice health-care telemedicine provider working with industry.
Beauregard D; Beauregard G
J Telemed Telecare; 2000; 6 Suppl 1():S107-9. PubMed ID: 10793990
[TBL] [Abstract][Full Text] [Related]
52. Subsidies versus intellectual property rights when innovators operate in two markets.
Skliaustyte E; Weber M
PLoS One; 2023; 18(4):e0284880. PubMed ID: 37093831
[TBL] [Abstract][Full Text] [Related]
53. Pledging intellectual property for COVID-19.
Contreras JL; Eisen M; Ganz A; Lemley M; Molloy J; Peters DM; Tietze F
Nat Biotechnol; 2020 Oct; 38(10):1146-1149. PubMed ID: 33020626
[No Abstract] [Full Text] [Related]
54. Learning, technology and intellectual property: a survey of the philosophies and preferences of our trainees and peers.
Bedoya MA; Back SJ; Scanlon MH; Delgado J; Darge K; Reid JR
Pediatr Radiol; 2016 Dec; 46(13):1780-1786. PubMed ID: 27543516
[TBL] [Abstract][Full Text] [Related]
55. Life sciences intellectual property licensing at the Massachusetts Institute of Technology.
Huang S; Siah KW; Vasileva D; Chen S; Nelsen L; Lo AW
Nat Biotechnol; 2021 Mar; 39(3):293-301. PubMed ID: 33692518
[TBL] [Abstract][Full Text] [Related]
56. A Short Introduction to Intellectual Property Rights.
Voss T; Paranjpe AS; Cook TG; Garrison NDW
Tech Vasc Interv Radiol; 2017 Jun; 20(2):116-120. PubMed ID: 28673648
[TBL] [Abstract][Full Text] [Related]
57. Function Mechanism of Intellectual Property Capability on Relay Innovation Based on CWLBGSO-DAG-Bootstrap SEM: Mediating Effect of Knowledge Matching and Moderating Effect of Relationship Learning.
Liu Q; Ding T; Li Y; Gao Z; Guo Y
Comput Intell Neurosci; 2022; 2022():4357917. PubMed ID: 35800701
[TBL] [Abstract][Full Text] [Related]
58. COVID-19 vaccines a global public good? Moving past the rhetoric and making work of sharing intellectual property rights, know-how and technology.
Meijer M; Verschuuren M; Weggen E
Eur J Public Health; 2021 Oct; 31(5):925-926. PubMed ID: 34473255
[No Abstract] [Full Text] [Related]
59. Who shall live when not all can live? Intellectual property in accessing and benefit-sharing influenza viruses through the World Health Organisation.
Lawson C
J Law Med; 2011 Mar; 18(3):554-76. PubMed ID: 21528740
[TBL] [Abstract][Full Text] [Related]
60. ECVAM's approach to intellectual property rights in the validation of alternative methods.
Linge JP; Hartung T
Altern Lab Anim; 2007 Aug; 35(4):441-6. PubMed ID: 17850189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
